# The Association Between TNFSF4 Polymorphism and CD

> **NCT07263464** · — · COMPLETED · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 818 (actual)

## Conditions studied

- Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
- Polymorphism, Single Nucleotide
- Ustekinumab

## Interventions

- **BIOLOGICAL:** Ustekinumab - Standard Dosage

## Key facts

- **NCT ID:** NCT07263464
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 818 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07263464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07263464, "The Association Between TNFSF4 Polymorphism and CD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07263464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*